Han Ji-Won, Youn Joong Kee, Oh Chaeyoun, Kim Hyun-Young, Jung Sung-Eun, Park Kwi-Won
Department of Surgery, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.
Department of Pediatric Surgery, Seoul National University Children's Hospital, Seoul, Republic of Korea.
Eur J Pediatr Surg. 2019 Oct;29(5):431-436. doi: 10.1055/s-0038-1667038. Epub 2018 Aug 1.
The treatment of Hirschsprung disease (HD) is pull-through (PT) surgery. Redo PT can be performed in 1 to 10% of patients after initial PT. In this study, we reviewed the causes and associated factors of redo PT.
We retrospectively reviewed medical charts of 657 patients with HD who underwent surgeries between September 1979 and January 2016. The indications for redo PT are as follows. First, there were persistent obstructive symptoms after the first operation, (1) with transition zone shown definitely on contrast study, (2) with anatomic problems, and (3) obstructive symptoms persist despite conservative or nonredo surgical treatment without (1) and (2). We analyzed the causes and associated factors of redo PT.
A total of 49 (7.5%) patients underwent redo PT. Among them, 41 and 8 patients underwent PT twice and three times, respectively. Among 57 cases of redo, the causes of redo included pathologic problem ( = 28)-aganglionosis ( = 20), hypoganglionosis ( = 4), immature ganglion cell ( = 4)-or anatomic problem ( = 21)-stricture ( = 13), fistula and/or abscess ( = 8) at anastomosis. Comparing associated factors between the nonredo and redo groups, the redo group had longer initial PT operation time ( = 0.001), more postoperative complications ( < 0.001), and more transanal endorectal PT (TERPT) approach as initial PTs ( < 0.001). According to causes of redo, the anatomic problem group underwent more third PTs than the pathologic problem group ( = 0.010).
Approximately 7.5% of patients experienced redo PT. The cause of redo included pathologic ( = 28) or anatomic problem ( = 21). Longer operation time, more complications, and TERPT were associated with redo. The anatomic problem group underwent more third PTs than the pathologic problem group.
先天性巨结肠症(HD)的治疗方法是拖出式(PT)手术。初次PT术后,1%至10%的患者可能需要再次进行PT手术。在本研究中,我们回顾了再次PT手术的原因及相关因素。
我们回顾性分析了1979年9月至2016年1月期间接受手术的657例HD患者的病历。再次PT手术的指征如下。首先,初次手术后存在持续性梗阻症状,(1)造影检查明确显示移行段,(2)存在解剖问题,(3)尽管进行了保守治疗或非再次手术治疗,但仍无(1)和(2)情况时梗阻症状持续存在。我们分析了再次PT手术的原因及相关因素。
共有49例(7.5%)患者接受了再次PT手术。其中,41例和8例患者分别接受了两次和三次PT手术。在57例再次手术病例中,再次手术的原因包括病理问题(=28例)——无神经节细胞症(=20例)、神经节细胞减少症(=4例)、神经节细胞未成熟(=4例)——或解剖问题(=21例)——吻合口狭窄(=13例)、瘘管和/或脓肿(=8例)。比较非再次手术组和再次手术组的相关因素,再次手术组初次PT手术时间更长(=0.001)、术后并发症更多(<0.001),且初次PT手术采用经肛门直肠拖出术(TERPT)的比例更高(<0.001)。根据再次手术的原因,解剖问题组接受第三次PT手术的比例高于病理问题组(=0.010)。
约7.5%的患者经历了再次PT手术。再次手术的原因包括病理(=28例)或解剖问题(=21例)。手术时间延长、并发症增多以及TERPT与再次手术相关。解剖问题组接受第三次PT手术的比例高于病理问题组。